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Background. Respiratory support is a vital method for temporary compensation of external breathing 
function in patients with severe traumatic brain injury. However, it is not always possible to deal with severe 
respiratory dysfunction even with the usage of up-to-date respiratory technologies. this work is aimed to find an 
answer how different pattern of mechanical ventilation influence on a treatment of patients with severe traumatic 
brain injury.
Objective.the influence of respiratory support, as a main method for temporary compensation of external 
breathing function, on treatment result for patients with severe traumatic brain injury.
Methods. Treatment results of 253 patients with severe traumatic brain injury of Ternopil University Hospital 
were evaluated due to the type of respiratory support used. The results were separately evaluated in alive and 
dead patients.
Results. Mortality rate of patients depended on the type of mechanical ventilation that was used. The highest 
mortality (58.69 %) was in the group, when a patient was transferred to forced ventilation a volume control. The 
mortality rate was decreasing by 51.78% in case of adding PEEP. The strategy of using accessory lung ventilation 
patterns cPaP and BiPaP caused significant (in 1.48 times) decrease of mortality in this group of patients.
Conclusions. The survival of patients with severe traumatic brain injury, who were ventilated by the method 
of consistent combination of forced ventilation with pressure control (cРv) and 2 patterns of accessory lung 
ventilation: Constant Positive Airway Pressure (CPAP) and Biphasic positive airway pressure (BiPAP), is reliably 
higher than in the case of forced ventilation with volume control with Positive end-expiratory pressure.
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Introduction
The process of treating the patients with 
severe traumatic brain injury (STBI) is a topical 
issue of contemporary medicine [1]. It is 
established that the mortality rate in case of 
STBI is 80%, it is caused by the development of 
multiple organ failure [2]. 
STBI is one of the causes of mortality and 
disability all over the world. It is also one of the 
main reasons of human mortality until the age 
of 40 [3]. In Great Britain STBI frequency is 1 500 
people per every 100 000 population. 9 patients 
out of 100 000 population die because of trau-
matic brain injury [1, 2]. The problem of STBI 
treatment is today not only medical, but social 
as well [2-5]. 
Among the complications of STBI the 
prominent role is given to lung affection which 
develops in 70–80% of patients and becomes 
one of the contributory factors for the worsening 
of the patient state with the further negative 
treatment results [4]. Morphological changes 
of lungs with underlying STBI are detected in 
95–97.7% of cases [4]. The most frequent cause 
of patients mortality on the 3–5th day of STBI is 
acute respiratory distress syndrome (ARDS) [2]. 
It happens in almost every STBI patient with 
multiple organ failure [6, 7].
Respiratory support is a main method for 
the temporary compensation of external bre-
athing function [8]. However, it is not always 
possible to deal with severe respiratory dys-
function even using up-to-date respiratory 
technologies. 
The question is: how will it influence the 
treatment result? This study is aimed to find an 
answer.
Material and Methods
Treatment results of 253 patients with STBI 
of Ternopil University Hospital were evaluated 
due to the type of respiratory support used. 
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The results were separately evaluated in alive 
and dead patients. As the criteria of treatment 
effectiveness we used the period of patients 
stay on mechanical ventilation. 
4 different patterns of breathing were used: 
independent or spontaneous breathing, forced 
ventilation with volume control (CMv) and 
forced ventilation with pressure control (CРV). 
We also used 2 patterns of accessory lung 
ventilation: Constant Positive Airway Pressure 
(CPAP) and Biphasic positive airway pressure 
(BiPAP), a type of ventilation with 2 phases of 
positive pressure in airway. For ventilation with 
volume control we used a mechanical ventilation 
device “Bryz”. For ventilation in CPAP, BiPAP 
and CРV modes we used a mechanical ventilator 
Carina Drager. 
In 2012–2015 years in Ternopil University 
Hospital there were 253 patients with STBI. 
Mechanical ventilation was delivered for all 
these patients. They were divided into 3 groups. 
In the 1st group patients were ventilated in CMv 
(5–6 ml/kg). The strategy in 2nd group was the 
same except during CMv mechanical ventilation 
we used positive pressure in the end of expi-
ration (PeeP), which didn’t exceed 6–9 mbar. In 
the 3rd group we used the accessory ventilation. 
If the saturation of these patients in case of 
independent breathing decreased more than 
by 92%, the accessory ventilation through endo-
tracheal tube in CPAP pattern or alternatively 
tracheostomy was implemented. If saturation 
was lower than 90%, patients were transferred 
to BiPAP pattern. In case of full absence of inde-
pendent breathing, the patient of this group 
was ventilated in CPv pattern. At this strategy 
PeeP didn’t exceed 6–9 mbar, and inspiratory 
pressure — 20–22 mbar.
Patients usually died because of multiple 
organ failure, which was followed by ARDS. 
ARDS was the most frequent cause of patients’ 
deaths during the first 5 days after the surgery. 
We used Guidelines for the Management of 
Severe Traumatic Brain Injury of American 
Asso ciation of Neurosurgeons (2007) as the 
treatment strategy which was modified accor­
ding to our conditions [4].
In all groups of patients during spontaneous 
breathing and mechanical ventilation as well, 
we tried not only to keep the partial oxygen 
pressure but also to prevent hypocapnia, so the 
hyperventilation didn’t occur. 
Infusion therapy was implemented in nor-
movolemic mode in order to avoid hypotension 
episodes. Additionally, we tried to keep central 
venous pressure on the level of 8–10 mm Hg 
and hemodynamic support with the usage of 
vasopressors was also performed. We also tried 
to prevent the decrease of average blood 
pressure (BP) lower than 80 mm Hg. dopamine 
and adrenaline were the most frequently used 
among the vasopressors. The highest point of 
systolic BP was 160 mm Hg. As for the infusion 
therapy we preferred Normal Saline Solution 
(NSS) or Ringer’s solution.
Analgosedation was used for eradicating 
hyperventilation and synchronization with ven-
tilator. The ventilation was implemented with 
PaCO2 35–40 mm Hg. PeeP was 5–8 mm Hg (not 
higher than 15 mm Hg). According to the treat-
ment strategy we also cured hyperthermia and 
anemia, prevented convulsions with carbama-
zepine and gabantin, used low molecular 
weight heparins at the absence of hemorrhage. 
For prevention of stress ulcers was conducted 
and nutrition therapy was applied. We preferred 
the fastest administration of enteric nutrition 
by means of standard food mixes and obligatory 
glycemia control. Corticosteroids (CS) were 
used only in case of ARDS development. If 
intracranial pressure was rising we also used 
barbiturates. Antibiotic therapy was chosen due 
to the type of microflora. The drugs of choice 
were meropenem, colomycin, amikacin.
The mortality rate and ventilation period in 
each studied group were counted. The venti-
lation period was counted separately: for those 
who stayed alive and died. 
The permission for research implementation 
was issued by the Commission on Bioethics of 
I. Horbachevsky Ternopil State Medical Uni-
versity (protocol №29 from May 20, 2015).
Results
Mortality rate of patients depended on the 
type of mechanical ventilation that was used. 
The highest mortality (58.69%) was in the 1st 
group, when the patient was transferred to CMv 
pattern in terms of insufficient independent 
breathing. The mortality rate decreased by 
51.78% when PeeP was added. The strategy of 
using accessory lung ventilation patterns CPAP 
and BiPAP caused significant (in 1.48 times) 
mortality decrease in this group of patients.
The usage of different ventilation patterns 
caused the changes in the period of patients’ 
stay on mechanical ventilation. In the 1st group 
(CMv), dead patients were on accessory ven-
tilation for very short period and died quickly. 
Patients, who stayed alive, adversely, stayed on 
mechanical ventilation for longer period. The 
accession of PEEP improved ventilation results: 
o. V. oliynyk et al.
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dead patients lived longer and those, who 
stayed alive, were taken of ventilator earlier. 
The best results were in groups with accessory 
ventilation patterns CPAP and BiPAP. Mortality 
in this group was lower than in 1st and 2nd 
groups. Among the alive patients with such 
mechanical ventilation support, the process of 
excluding patients from mechanical ventilation 
was much easier, though the mortality in this 
group was in average for a few days longer if 
compared to 1st and 2nd group.
Discussion
To our mind, the obtained results depend 
on peculiarities of ventilation pattern and 
analgosedation. Anesthesiologists always see 
that a patient feels pain because vital signs, 
above all pulse, BP and respiratory rate 
increase. However, we tried not to use the 
excessive dosages of analgesics. If there are no 
signs of pain, we could give no analgesics to a 
patient at all. In case of even small signs of pain 
we prescribed narcotic analgesics. Frequently, 
even not high dosage of analgesics caused the 
impairment of patients’ state. Patient started 
breathing worse and mechanical ventilation 
was necessary. The same situation was on in 
case of hyperventilation, which promoted hy-
percapnia development. even small dosages of 
analgesics caused the decrease in patients’ 
state according to GCS level, partial oxygen 
pressure in arterial blood less than 60 mm Hg 
and promoted the necessity of mechanical 
ventilation. 
The main differences and advantages of 
accessory ventilation are: in CPAP pattern the 
ventilator helps the patient to inhale even if 
there are 40 inhales per 1 minute. The ventilator 
will support the positive pressure in the end of 
exhale on the determined level, which equals 
6-9 cm of water. Also, it helps to make every 
effort of inhale according to determined mea-
surement of inspiratory support (20 mBar). In 
BiPAP pattern the respiratory rate is maintained 
by a ventilator. Inhalation startS by the patients’ 
effort to inhale, and then the inspiratory 
support level is achieved. The important thing 
is that patient can breathe independently and 
breathe between respiratory cycles, which are 
provided by mechanical ventilation. In order to 
achieve the synchronization with it, we need 
smaller dosages of analgesics. We observed the 
smaller interruption of consciousness and 
breathing due to GCS 
During the last year we succeed in mortality 
decrease almost in 4 times: before the rate was 
9 to 100 000 and now it is 9 up to 200 000. The 
main causes of this are 2 main factors: the 
earlier described strategy of respiratory 
support and the CS in treatment of ARDS. 
The most significant problem of intensive 
care unit is increase of bacteria resistance to 
carbapenem. In terms of insufficient financial 
support it is hard to solve.
Table 1. Treatment results of patients with STBI followed by severe sepsis  
and ARDS depending on type of respiratory support and CS usage
ventilation mode
Amount  
of patients Average age
ventilation period  
in days Survival, %
SV+ ІMV Alive 19 37.52 19.47 58.69
Dead 27 52.96 5.22
SV+ІMV+PEEP Alive 27 41.0 17.14 51.78
Dead 29 52.1 6.76
CPAP+BiPAP+CPv Alive 91 40.85 13.93 39.73
Dead 60 50.0 14.1
Dead patients
SV+ІMV SV+ІMV+PEEP CPAP+BiPAP+CPv
SV+ІMV – 0.0734 0.000050
SV+ІMV+PEEP 0.0734 – 0.000099
CPAP+BiPAP+CPv 0.000050 0.000099 –
Alive patients
SV+ІMV SV+ІMV+PEEP CPAP+BiPAP+CPv
SV+ІMV – 0.8194 0.1769
SV+ІMV+PEEP 0.8194 – 0.4688
CPAP+BiPAP+CPv 0.1769 0.4688 –
o. V. oliynyk et al.
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Conclusions
The survival of patients with STBI which 
were ventilated by consistent combination of 
forced ventilation with the pressure control 
(CРV) and 2 patterns of accessory lung venti­
lation: Constant Positive Airway Pressure 
(CPAP) and Biphasic positive airway pressure 
(BiPAP) is significantly higher than in the case 
of forced ventilation with the volume control 
with Positive end-expiratory pressure.
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